Résumé IA
Nous avons examiné 6378 résultats en direct pour biosimilar technical development et retenu les 3 options qui semblent les plus utiles à comparer en premier.
Les thèmes les plus forts dans cette sélection sont Oncology et Biosimilars.
Nous avons examiné 6378 résultats en direct pour biosimilar technical development et retenu les 3 options qui semblent les plus utiles à comparer en premier.
Les thèmes les plus forts dans cette sélection sont Oncology et Biosimilars.
Source: Lek (a Sandoz company)
Description
End-to-end technical development and production of biosimilars and complex generics, utilizing state-of-the-art facilities for drug optimization and large-scale pharmaceutical manufacturing.
Idéal pour
Biosimilar production, Complex generics, Pharmaceutical manufacturing et Industrial scale Up
Évaluation
Source: Biocon Biologics Philippines Inc.
Description
An oncology biosimilar used in the treatment of various solid tumors, expanding therapeutic options for cancer patients.
Idéal pour
Solid tumor treatment, Cancer therapy et Oncology clinics
Évaluation
Source: Biocon Biologics Philippines Inc.
Description
A biosimilar monoclonal antibody for the treatment of HER2-positive breast and gastric cancers, available in the Philippines since 2018.
Idéal pour
HER2 Positive breast cancer, Gastric cancer treatment et Oncology therapy
Évaluation
| Comparer | Biosimilar Technical Development | Bevacizumab Biosimilar | Trastuzumab Biosimilar |
|---|---|---|---|
| Source | Lek (a Sandoz company) | Biocon Biologics Philippines Inc. | Biocon Biologics Philippines Inc. |
| Description | End-to-end technical development and production of biosimilars and complex generics, utilizing state-of-the-art facilities for drug optimization and large-scale pharmaceutical manufacturing. | An oncology biosimilar used in the treatment of various solid tumors, expanding therapeutic options for cancer patients. | A biosimilar monoclonal antibody for the treatment of HER2-positive breast and gastric cancers, available in the Philippines since 2018. |
| Idéal pour | Biosimilar production, Complex generics, Pharmaceutical manufacturing et Industrial scale Up | Solid tumor treatment, Cancer therapy et Oncology clinics | HER2 Positive breast cancer, Gastric cancer treatment et Oncology therapy |
| Action | |||
| Évaluation |
Si vous voulez commencer par l'option la plus équilibrée, je vous recommande :
"Biosimilar Technical Development de Lek (a Sandoz company)."
Je l'ai choisi parce que As a global competence center for Sandoz, Lek provides industry-leading expertise in biosimilars and complex pharmaceutical drug optimization.